Cargando…
hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations
BACKGROUND: Expression of ABCG2 is normally absent or low in the pancreas, but high in human pancreatic cancer cells. The mechanism by which ABCG2 is altered in human cancers remains unknown. METHODS: We investigated ABCG2 expression in four pancreatic cancer cell lines, and used three microRNA (miR...
Autores principales: | Wang, F, Xue, X, Wei, J, An, Y, Yao, J, Cai, H, Wu, J, Dai, C, Qian, Z, Xu, Z, Miao, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939772/ https://www.ncbi.nlm.nih.gov/pubmed/20628378 http://dx.doi.org/10.1038/sj.bjc.6605724 |
Ejemplares similares
-
Hsa-miR-520d Converts Fibroblasts into CD105+ Populations
por: Ishihara, Yoshitaka, et al.
Publicado: (2014) -
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
por: Robey, R W, et al.
Publicado: (2003) -
Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008) -
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
por: Iwagami, Y, et al.
Publicado: (2013) -
Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
por: Feng, Linxiang, et al.
Publicado: (2023)